Standards & Guidelines

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Michelle Kittleson,

Watch time: 6m 19s
ACC.23 President Interview With Dr B Hadley Wilson

B Hadley Wilson,

Watch time: 15m 9s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

ACC 23 Late-breaker Discussion: The BETTER-CARE HF Trial

Harriette Van Spall, Amrita Mukhopadhyay,

Watch time: 14m 3s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
EP 84: Mastering the Art of Patient Care with Dr Kittleson

Ankur Kalra, Michelle Kittleson,

Listen time: 49m 30s
EP 83: Sham Peer Reviews: A Deep Dive with Dr Lawrence Huntoon

Listen time: 40:08
Ep 82: Hospital Peer Review Process: What You Need to Know as a Physician

Ankur Kalra, Amir Kaki, , et al

Listen time: 55m 32s

Katie Caldwell , Alan Moore , Taylor Rali ,

Read time: 9 Mins
Heart Failure in Focus Podcast - Ep 4: Mitigating Clinical Inertia in Heart Failure

Muthiah Vaduganathan, Tariq Ahmad,

Listen time: 23m 39s
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 35m 25s

Lisa LeMond , Sarah J Goodlin ,

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

A Changing Paradigm: Defining the Future Role of SGLT-2 Inhibitors

Andrew JS Coats, Biykem Bozkurt, Carolyn Lam, et al

Gianluigi Savarese , Lars H Lund ,

Samia R Toukhsati , Andrea Driscoll , David L Hare ,

Antoni Bayés-Genís, Julio Núñez,

ESC 2021 Discussion: The EMPEROR-Preserved Trial

Stefan Anker, Harriette Van Spall,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

European Heart Failure Guideline Updates: A Peer-to-Peer Discussion on SGLT-2 Inhibitors

Andrew JS Coats, Carolyn Lam,

Ivan Milinkovic , Giuseppe Rosano , Yury Lopatin , et al

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 3h 51m (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

About

Guidelines and recommendations are designed to guide physicians in making decisions in daily practice. They provide a condensed, graded summary of all available evidence at the time of writing, allowing clinicians to make evidence-based choices for their patients.

Media

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Michelle Kittleson,

Watch time: 6m 19s
ACC.23 President Interview With Dr B Hadley Wilson

B Hadley Wilson,

Watch time: 15m 9s

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

ACC 23 Late-breaker Discussion: The BETTER-CARE HF Trial

Harriette Van Spall, Amrita Mukhopadhyay,

Watch time: 14m 3s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
EP 84: Mastering the Art of Patient Care with Dr Kittleson

Ankur Kalra, Michelle Kittleson,

Listen time: 49m 30s
EP 83: Sham Peer Reviews: A Deep Dive with Dr Lawrence Huntoon

Listen time: 40:08
Ep 82: Hospital Peer Review Process: What You Need to Know as a Physician

Ankur Kalra, Amir Kaki, , et al

Listen time: 55m 32s
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 35m 25s

AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Alexandre Mebazaa, Harriette Van Spall,

Watch time: 21m 14s

Joseph A Hill, Mirvat Alasnag,

View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 3:52:31
Masterclass: Evidence on the Use of SGLT2is in HF Across the EF Spectrum

Scott Solomon, Harriette Van Spall, Mikhail Kosiborod, et al

Watch time: 29m 37s

Mikhail Kosiborod, Cecilia Linde, Marat Fudim, et al

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22 Late-breaker Discussion: The PROMPT-HF Trial

Gregg C Fonarow, Tariq Ahmad, Harriette Van Spall, et al

AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study

Harriette Van Spall, ,

AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial

Harriette Van Spall, John Spertus,

View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

View from the Thoraxcenter: AHA 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Association Between AID/FID with Incident CV Disease and Mortality

Benedikt Schrage,

View from the Thoraxcenter: TCT 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Andrew JS Coats, Shelley Zieroth, Javed Butler, et al

Aktualisierungen der europäischen Leitlinien zur Herzinsuffizienz: Eine Peer-to-Peer-Diskussion über SGLT-2-Hemmer

Gerd Hasenfuß, Michael Böhm, Stefan Anker, et al

Antoni Bayés-Genís, Julio Núñez,

Media

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Michelle Kittleson,

Watch time: 6m 19s
ACC.23 President Interview With Dr B Hadley Wilson

B Hadley Wilson,

Watch time: 15m 9s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s

Mirvat Alasnag, Khaled Al-Shaibi, Erin D Michos, et al

ACC 23 Late-breaker Discussion: The BETTER-CARE HF Trial

Harriette Van Spall, Amrita Mukhopadhyay,

Watch time: 14m 3s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
EP 84: Mastering the Art of Patient Care with Dr Kittleson

Ankur Kalra, Michelle Kittleson,

Listen time: 49m 30s
EP 83: Sham Peer Reviews: A Deep Dive with Dr Lawrence Huntoon

Listen time: 40:08
Ep 82: Hospital Peer Review Process: What You Need to Know as a Physician

Ankur Kalra, Amir Kaki, , et al

Listen time: 55m 32s
Heart Failure in Focus Podcast - Ep 4: Mitigating Clinical Inertia in Heart Failure

Muthiah Vaduganathan, Tariq Ahmad,

Listen time: 23m 39s
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 35m 25s

AHA 22: Late-Breaker Discussion: The STRONG-HF Trial

Alexandre Mebazaa, Harriette Van Spall,

Watch time: 21m 14s

Joseph A Hill, Mirvat Alasnag,

View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33:18

Watch time: 3:52:31

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 3h 51m (47 videos)
Masterclass: Evidence on the Use of SGLT2is in HF Across the EF Spectrum

Scott Solomon, Harriette Van Spall, Mikhail Kosiborod, et al

Watch time: 29m 37s

Mikhail Kosiborod, Cecilia Linde, Marat Fudim, et al

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

HF 2022: Heart Failure Highlights of 2022 with Prof Cleland

John GF Cleland,

HF 22: Chronic & Acute HF Guidelines for Patients: Improving Patient Care

Tiny Jaarsma,

View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22 Late-breaker Discussion: The PROMPT-HF Trial

Gregg C Fonarow, Tariq Ahmad, Harriette Van Spall, et al

AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study

Harriette Van Spall, ,

AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial

Harriette Van Spall, John Spertus,

Anushka Patel, Stephen Nicholls, Jeffrey Weitz, et al

Articles

Foreword

Andrew JS Coats

,

Giuseppe Rosano

,

Citation:

Cardiac Failure Review 2017;3(1):5–6

DOI:

https://doi.org/10.15420/cfr.2017:3:1:5
  • Views: Views 179
  • Downloads: Downloads 0

Global Public Health Burden of Heart Failure

Gianluigi Savarese

,

Lars H Lund

,

Citation:

Cardiac Failure Review 2017;3(1):7–11.

DOI:

https://doi.org/10.15420/cfr.2016:25:2
  • Views: Views 12833
  • Downloads: Downloads 74
  • Citations: 1268

The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines

Ivan Milinkovic

,

Giuseppe Rosano

,

Yury Lopatin

,

Petar M Seferovic

,

Citation:

Cardiac Failure Review, 2016;2(2):123–9

DOI:

https://doi.org/10.15420/cfr.2016:13:1
  • Views: Views 5170
  • Downloads: Downloads 11
  • Citations: 5

What the General Practitioner Needs to Know About Their Chronic Heart Failure Patient

Frans H Rutten

,

Joe Gallagher

,

Citation:

Cardiac Failure Review 2016;2(2):79–84

DOI:

https://doi.org/10.15420/cfr.2016:18:1
  • Views: Views 1443
  • Downloads: Downloads 16
  • Citations: 3